(Q44849430)

6 December 2017

Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder (English)

1 reference

6 December 2017

1 reference

Gabriele Sachs

2

0 references

author name string

Peter Berger

1

1 reference

6 December 2017

Michaela Amering

3

1 reference

6 December 2017

Anita Holzinger

4

1 reference

6 December 2017

Bettina Bankier

5

1 reference

6 December 2017

Heinz Katschnig

6

1 reference

6 December 2017

1 May 2004

1 reference

Journal of Affective Disorders

6 December 2017

1 reference

6 December 2017

80

1 reference

6 December 2017

75-78

1 reference

6 December 2017

1

1 reference

Embarrassment about the first panic attack predicts agoraphobia in panic disorder patients

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

Respiratory training prior to exposure in vivo in the treatment of panic disorder with agoraphobia: efficacy and predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

The impact of personality disorders on treatment outcome of anxiety disorders: best-evidence synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

The International Personality Disorder Examination. The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

Diazepam and Propranolol in Panic Disorder and Agoraphobia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

Predictors of response to alprazolam and placebo in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2803%2900043-0

7 January 2021

10.1016/S0165-0327(03)00043-0

Identifiers

DOI

1 reference

6 December 2017

1 reference